We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Interim FDA Chief Appreciates Value of Medical Technology, Industry Group Says
Interim FDA Chief Appreciates Value of Medical Technology, Industry Group Says
September 30, 2005
The medical device industry has praised the Bush administration’s selection of Andrew von Eschenbach to become acting FDA commissioner, noting his prior career as a cancer surgeon gives him a real-world appreciation of the value of advanced medical technology.